Clinical trial · Observational
Contemporary Characteristics of Penile Cancer
Contemporary Characteristics of Penile Carcinoma: at M.D. Anderson Cancer Center, and Harris Health System and Katy, Sugar Land, the Woodlands and Bay Area Regional Care Centers
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): \<75% participation
Summary
Brief summary (as posted)
This study develops a prospective database of patients who are evaluated and treated for penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors, treatment, complications, and tumor progression. It will also prospectively validate the importance of pathological prognostic factors previously reported and outcome related to contemporary treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Penile Carcinoma | Penile Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Squamous Cell Carcinoma of the Penis | Penile Squamous Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Data Capture | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational (data collection)
- description
- Patients undergo data collection every 6 months for up to 15 years.
- interventionNames
- Other: Data Capture
- Other: Questionnaire Administration
Primary outcomes (1)
- measure
- Prospectively collect data on the presenting features, management and outcome of penile carcinoma
- timeFrame
- Up to 15 years
- description
- Descriptive statistics will be utilized where applicable to address questions relevant to the study aims.
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * All diagnosed patients with a primary penile malignancy, including those with squamous carcinoma Exclusion Criteria: * No patient meeting the above criteria will be excluded
References
Publications (0)
Data not yet available